SILENCE THERAPEUTICS PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.65 USD | +3.97% |
|
+1.81% | +13.13% |
Chart calendar Silence Therapeutics plc
224b3eacc0aa50612.UJoR0-YcsibevNyyY8CjdevooKrNgLH7EgPF1wnx12w.EdNe5tF2_nyB1bfjNY3oHqa-le38ufOuSjDwk2q0pTk4836-kyvKFKbX7A~1950c207acde90d5938914130d4de4c3
Upcoming events on Silence Therapeutics plc
Past events on Silence Therapeutics plc
| 07/06/2024 12:00 am | Jefferies Global Healthcare Conference |
| 21/05/2024 12:00 am | H.C. Wainwright BioConnect Investor Conference |
| 17/05/2024 05:30 pm | Annual General Meeting |
| 16/05/2024 06:00 pm | Q1 2024 Earnings Release |
| 13/03/2024 05:30 pm | Q4 2023 Earnings Call |
| 13/03/2024 04:35 pm | Q4 2023 Earnings Release |
| 08/02/2024 12:00 am | Guggenheim Healthcare Talks Biotechnology Conference - Fireside Chat |
| 15/11/2023 10:00 pm | Jefferies London Healthcare Conference |
| 14/11/2023 05:30 pm | Q3 2023 Earnings Release |
| 03/10/2023 05:30 pm | Chardan Genetic Medicines Conference |
| 28/09/2023 01:40 am | Cantor Global Healthcare Conference |
| 12/09/2023 07:30 pm | H.C. Wainwright Global Investment Conference |
| 11/09/2023 06:50 pm | Morgan Stanley Global Healthcare Conference |
| 16/08/2023 04:30 pm | Q2 2023 Earnings Release |
| 08/06/2023 01:30 am | Jefferies Global Healthcare Conference |
| 17/05/2023 01:30 am | Q1 2023 Earnings Release |
| 03/05/2023 01:00 am | H.C. Wainwright BioConnect Investor Conference |
| 27/04/2023 08:30 pm | Annual General Meeting |
| 04/04/2023 11:40 pm | Guggenheim Genomic Medicines and Rare Disease Day - Fireside Chat |
| 15/03/2023 05:30 pm | Q4 2022 Earnings Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million GBP | Released Forecast Spread | 0,24 1,83 -86.63% | 5,48 6,35 -13.73% | 12,4 13,5 -8.22% | 17,5 23,7 -26.26% | 25,4 29,0 -12.5% | 27,2 |
|
EBITDA Million GBP | Released Forecast Spread | -22,3 -18,1 -23.14% | -35,4 -23,2 -52.24% | -45,4 -39,3 -15.49% | -48,1 0,00 - | -49,1 -54,9 10.61% | -53,9 |
|
EBIT Million GBP | Released Forecast Spread | -22,7 -17,6 -28.86% | -35,8 -26,8 -33.59% | -45,8 -44,5 -3.06% | -48,6 -42,7 -13.87% | -49,6 -46,4 -6.93% | -50,0 |
|
Earnings before Tax (EBT) Million GBP | Released Forecast Spread | -22,9 -18,0 -27.1% | -36,0 -26,7 -34.74% | -45,9 -45,8 -0.04% | -47,4 -39,9 -18.69% | -50,3 -41,6 -20.8% | -47,6 |
|
Net income Million GBP | Released Forecast Spread | -19,6 -14,8 -32.06% | -32,5 -22,5 -44.97% | -39,4 -42,8 7.83% | -40,5 -33,0 -22.69% | -43,3 -34,4 -25.95% | -41,3 |
|
EPS USD | Released Forecast Spread | 0,00 0,00 - | -1,64 -1,35 -21.64% | -1,74 -2,36 26.27% | -1,53 -1,55 1.54% | -1,49 -0,86 -73.74% | -0,39 |
| Announcement Date | 14/04/20 | 30/03/21 | 17/03/22 | 15/03/23 | 13/03/24 | - |
Quarterly results
| Fiscal Period | December | 2020 S1 | 2020 S2 | 2021 S1 | 2021 S2 | 2022 Q1 | 2022 Q2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2022 S2 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million GBP | Released Forecast Spread | 1,15 1,80 -36.33% | 4,33 1,18 266.58% | 5,85 2,17 169.79% | 6,57 6,72 -2.26% | 5,72 0,00 - | 3,64 2,04 78.58% | 9,37 9,53 -1.7% | 3,37 1,50 124.73% | 4,77 16,8 -71.55% | 8,14 11,2 -27.6% | 11,4 2,50 354.96% | 9,10 3,07 196.87% | 2,80 2,40 16.58% | 2,10 9,20 -77.18% | 12,4 3,55 249.46% | 9,85 | 3,60 | 3,60 | 3,55 | 3,50 |
|
EBITDA Million GBP | Released Forecast Spread | -14,0 -18,3 23.61% | -22,0 | -9,21 | -14,0 | -13,5 | -13,5 | -14,6 | -15,7 | ||||||||||||
|
EBIT Million GBP | Released Forecast Spread | -14,2 -18,3 22.44% | -21,7 -20,3 -6.86% | -22,3 -21,7 -2.58% | -23,5 -24,7 4.7% | -9,92 -15,0 33.85% | -14,1 -13,9 -1.58% | -24,0 -23,1 -3.83% | -13,6 -15,2 10.66% | -11,0 -0,08 -13026.95% | -24,6 -28,6 14.08% | -12,1 -14,0 13.07% | -11,5 -16,3 29.54% | -12,7 -16,5 23.15% | -13,3 -6,28 -111.92% | -4,16 -12,5 66.75% | -13,6 | -14,7 | -15,8 | ||
|
Earnings before Tax (EBT) Million GBP | Released Forecast Spread | -13,3 -18,3 27.16% | -22,7 -20,0 -13.62% | -22,6 -22,2 -1.54% | -23,3 -25,0 6.95% | -9,57 -15,0 36.19% | -13,4 -13,7 2.04% | -23,0 -22,9 -0.59% | -9,33 -15,1 38.21% | -15,1 -2,26 -564.75% | -24,4 -27,6 11.65% | -12,7 -13,9 8.74% | -12,0 -16,2 25.9% | -10,7 -16,5 35.32% | -15,0 -6,28 -138.48% | -3,37 -12,5 73.08% | -13,6 | -14,7 | -15,8 | ||
|
Net income Million GBP | Released Forecast Spread | -11,0 -16,8 34.35% | -21,5 -17,7 -21.89% | -20,0 -20,9 4.03% | -19,4 -27,5 29.71% | -7,68 -13,1 41.43% | -11,9 -12,4 3.54% | -19,6 -26,8 26.71% | -7,10 -13,7 47.99% | -20,6 -0,82 -2428.11% | -27,7 -24,2 -14.54% | -10,2 -12,5 18.57% | -10,4 -15,1 31.01% | -8,25 -15,2 45.75% | -14,4 -5,48 -163.21% | -1,88 -2,90 35.31% | -12,0 | -13,1 | -14,2 | ||
|
EPS USD | Released Forecast Spread | -1,07 -0,81 -31.98% | -0,95 -0,96 1.54% | -0,85 -1,24 31.56% | -0,49 | -0,80 -1,09 26.39% | -0,48 | -0,73 -0,79 8.08% | -0,36 | -0,37 -0,67 45.26% | -0,27 -0,59 53.62% | -0,48 -0,20 -139.24% | -0,05 -0,03 -98.95% | -0,09 | -0,13 | -0,13 | -0,14 | -0,15 | |||
| Announcement Date | 14/09/20 | 30/03/21 | 12/08/21 | 17/03/22 | 16/05/22 | 11/08/22 | 11/08/22 | 10/11/22 | 15/03/23 | 15/03/23 | 16/05/23 | 16/08/23 | 14/11/23 | 13/03/24 | 16/05/24 | - | - | - | - | - |
Past sector events for Silence Therapeutics plc
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SLN Stock
- Calendar Silence Therapeutics plc
